Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Change in Inventory (2017 - 2019)

Historic Change in Inventory for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q3 2019 value amounting to $451000.0.

  • Ironwood Pharmaceuticals' Change in Inventory rose 26164.87% to $451000.0 in Q3 2019 from the same period last year, while for Dec 2020 it was $934000.0, marking a year-over-year change of. This contributed to the annual value of -$648000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Change in Inventory of $451000.0 as of Q3 2019, which was up 26164.87% from $483000.0 recorded in Q2 2019.
  • Ironwood Pharmaceuticals' Change in Inventory's 5-year high stood at $768000.0 during Q1 2018, with a 5-year trough of -$1.0 million in Q2 2017.
  • For the 4-year period, Ironwood Pharmaceuticals' Change in Inventory averaged around $140181.8, with its median value being $152000.0 (2019).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Change in Inventory tumbled by 10031.65% in 2015 and then skyrocketed by 118169.01% in 2018.
  • Quarter analysis of 4 years shows Ironwood Pharmaceuticals' Change in Inventory stood at -$4000.0 in 2015, then surged by 18475.0% to $735000.0 in 2017, then plummeted by 87.35% to $93000.0 in 2018, then surged by 384.95% to $451000.0 in 2019.
  • Its last three reported values are $451000.0 in Q3 2019, $483000.0 for Q2 2019, and $152000.0 during Q1 2019.